Generic drug maker Actavis Inc (NYSE: ACT) announced on Monday that it has agreed to acquire specialty pharmaceutical Company, Warner Chilcott Plc (NASDAQ: WCRX) in stock swap deal, valued at almost $5 billion.
Continue reading Actavis To Acquire Warner Chilcott (ACT, WCRX)